SNF8

SNF8 (also known as EAP30/VPS22) is a core subunit of the ESCRT-II complex that functions in endosomal sorting of ubiquitinated membrane receptors and also participates in nuclear transcriptional regulation. As an ESCRT-II component, SNF8 is required for sorting ubiquitinated EGFR and CXCR4 into multivesicular bodies for lysosomal degradation, with its membrane recruitment mediated by direct interaction of its N-terminal region with RILP (PMID:17714434, PMID:16857164). In the nucleus, SNF8 serves dual transcriptional roles: it associates with the ELL elongation complex to derepress RNA Pol II elongation activity (PMID:10419521), and it forms a virus-inducible complex with IRF3 and CBP that is essential for IRF3 binding to IFN-β/IFN-λ1 promoters and antiviral interferon gene induction (PMID:29084253). SNF8 additionally modulates TRPC6 channel currents and downstream NFAT activation through direct interaction with the TRPC6 cytoplasmic domain, independent of effects on channel surface expression (PMID:23171048).

1. 1995 Medium

   Establishing SNF8 as a transcriptional regulator: genetic analysis in yeast showed that SNF8 is required for glucose-regulated SUC2 gene derepression and is functionally related to SNF7 but genetically distinct from SNF1/SNF4 and SWI/SNF groups, defining it as part of a separate chromatin/transcription regulatory pathway.

   Evidence Gene disruption, genetic epistasis, and invertase derepression assays in S. cerevisiae

   PMID:7785322

   Open questions at the time

   • Molecular mechanism of SNF8-dependent transcriptional derepression in yeast was not defined
   • Whether SNF8 functions as part of a stable complex in yeast was unknown
   • Relationship to endosomal sorting function not yet recognized
2. 1999 Medium

   Identifying a direct transcriptional mechanism: EAP30/SNF8 was found as a subunit of the mammalian ELL elongation complex, where it directly binds ELL and derepresses ELL's inhibitory effect on RNA Pol II transcription, providing the first biochemical activity for SNF8 in metazoans.

   Evidence Co-purification of the ELL complex and in vitro transcription assay measuring RNA Pol II derepression

   PMID:10419521

   Open questions at the time

   • In vivo relevance of ELL complex derepression not demonstrated
   • Whether EAP30 has functions independent of ELL was unknown
   • Target gene specificity of ELL-EAP30 complex not defined
3. 2005 Medium

   Revealing a role in centrosome/SPB maturation: the fission yeast SNF8 ortholog Dot2 negatively regulates spindle pole body maturation, with dot2 mutants showing excess MTOC material and multipolar spindles that are suppressed by reducing Pcp1/pericentrin, placing SNF8 upstream of centrosome component homeostasis.

   Evidence Mutant analysis with electron microscopy and genetic epistasis (pcp1 suppression) in S. pombe

   PMID:15992541

   Open questions at the time

   • Whether this reflects an ESCRT-II-dependent or ESCRT-II-independent function was not determined
   • Mechanism by which Dot2 regulates Pcp1 levels was not identified
   • Conservation of this SPB role in mammalian cells untested
4. 2006 Medium

   Defining the membrane recruitment mechanism: RILP was shown to interact directly with the N-terminal half of VPS22/SNF8 and to recruit ESCRT-II to endosomal membranes, connecting Rab7-RILP signaling to ESCRT-II-mediated receptor sorting.

   Evidence Yeast two-hybrid, co-immunoprecipitation, confocal colocalization, and EGF sorting assays in mammalian cells; confirmed by two independent labs

   PMID:16857164 PMID:17010938

   Open questions at the time

   • Whether RILP is the sole recruitment factor for ESCRT-II was not resolved
   • Structural basis of the RILP–VPS22 interaction not determined
   • Relative contribution of RILP versus lipid-binding (VPS36) to ESCRT-II membrane association unclear
5. 2007 High

   Establishing the core endosomal sorting function: siRNA depletion of VPS22/SNF8 in HeLa cells demonstrated that ESCRT-II is required for lysosomal degradation of EGFR and CXCR4 and for normal MVB biogenesis, while showing that EGF-induced ERK signaling is terminated prior to ESCRT-II engagement — distinguishing ESCRT-II's role from upstream ESCRT-0/I in signal attenuation.

   Evidence siRNA knockdown with EGFR degradation kinetics, confocal microscopy of MVB morphology, and ERK1/2 phosphorylation/translocation assays in HeLa cells

   PMID:17714434

   Open questions at the time

   • Range of cargo receptors requiring ESCRT-II beyond EGFR/CXCR4 not systematically defined
   • Whether ESCRT-II has cargo-selective versus general roles in MVB formation not resolved
6. 2009 Low

   Suggesting competition for SNF8 between transcription and replication complexes: MCM2 was found to bind EAP30/SNF8 and compete with ELL for the same binding site, raising the possibility that SNF8 coordinates elongation and initiation activities.

   Evidence Co-immunoprecipitation and competition binding assay

   PMID:19819239

   Open questions at the time

   • Single-method co-IP without functional transcription or replication readout
   • Physiological context in which MCM2-EAP30 interaction is relevant not established
   • No independent confirmation of the competition model
7. 2012 Medium

   Uncovering a non-ESCRT channel-regulatory function: SNF8 was found to bind the TRPC6 cytoplasmic domain and enhance TRPC6-mediated currents and downstream NFAT transcriptional activation without altering channel surface expression, identifying SNF8 as a modulator of ion channel gating.

   Evidence Yeast two-hybrid, co-immunoprecipitation, whole-cell patch clamp electrophysiology, NFAT-luciferase reporter, surface biotinylation, and RNAi in mammalian cells

   PMID:23171048

   Open questions at the time

   • Mechanism by which SNF8 enhances TRPC6 currents (gating vs. conductance) not resolved
   • Whether this is an ESCRT-II-dependent or SNF8-autonomous function unknown
   • In vivo physiological relevance (e.g., in podocytes) not tested
8. 2017 High

   Establishing a nuclear role in innate antiviral immunity: SNF8 was shown to form a virus-inducible nuclear complex with IRF3 and CBP that is required for IRF3 binding to IFN-β/IFN-λ1/ISG56 promoters and for type I/III interferon induction, acting downstream of IRF3 phosphorylation and independently of NF-κB signaling.

   Evidence siRNA knockdown with IFN/ISG induction assays, nuclear fractionation, co-immunoprecipitation of EAP30–IRF3–CBP, ChIP for IRF3 at promoters, and antiviral assays (VSV, HCV)

   PMID:29084253

   Open questions at the time

   • Whether SNF8 recruits chromatin remodeling or additional coactivators to IRF3 targets not determined
   • Structural basis of the IRF3–EAP30–CBP ternary complex unknown
   • Whether ESCRT-II partners VPS25/VPS36 participate in the nuclear antiviral function not tested
9. 2020 Medium

   Linking ESCRT-II to longevity regulation: in C. elegans, VPS-22/SNF8 promotes nuclear localization of DAF-16/FOXO and acts in the same genetic pathway, with DAF-16 overexpression rescuing the short-lived phenotype of vps-22 knockdown, positioning SNF8 upstream of FOXO-dependent longevity.

   Evidence RNAi lifespan assay, daf-16 epistasis, DAF-16::GFP nuclear localization, and target gene expression in C. elegans

   PMID:32829877

   Open questions at the time

   • Whether the effect on DAF-16 localization is direct or via endosomal signaling regulation not resolved
   • Conservation in mammalian aging pathways not tested
   • Which endosomal cargo drives the longevity phenotype is unknown

• How SNF8 partitions between its ESCRT-II endosomal function and its nuclear transcriptional/antiviral roles remains unresolved, as does whether these represent independent or coordinated activities.
• No regulatory mechanism identified that switches SNF8 between endosomal and nuclear pools
• No structural model of full-length human ESCRT-II with SNF8 in a membrane-associated state
• Systematic identification of SNF8-dependent cargo in mammalian cells not performed